Atherosclerotic Cardiovascular Disease Risk Profile of Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate

BACKGROUND: In human immunodeficiency virus (HIV) treatment, tenofovir alafenamide (TAF) is associated with greater increases in all fasting cholesterol subgroups compared with tenofovir disoproxil fumarate (TDF). Because lipid abnormalities may contribute to cardiovascular morbidity and mortality,...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Open Forum Infect Dis
Autori principali: Huhn, Gregory D, Shamblaw, David J, Baril, Jean-Guy, Hsue, Priscilla Y, Mills, Brittany L, Nguyen-Cleary, Thai, McCallister, Scott, Das, Moupali
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2019
Soggetti:
Major Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6954396/
https://ncbi.nlm.nih.gov/pubmed/31950070
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz472
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi